IRIS
PONTREMOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.256
Totale 21.256
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.256
Totale 21.256
Salva come PNG Salva come JPEG
Città #
Genova 16.085
Rapallo 2.135
Genoa 1.866
Vado Ligure 1.131
Bordighera 39
Totale 21.256
Salva come PNG Salva come JPEG
Nome #
Left ventricular dilatation and subclinical renal damage in primary hypertension 174
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 166
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 164
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 148
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 148
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 144
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 143
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 142
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 140
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 136
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 133
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 131
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 131
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 131
Cardiovascular and renal effects of hyperuricaemia and gout. 129
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 129
C-reactive protein and target organ damage in untreated patients with primary hypertension. 129
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 129
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 129
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 128
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 127
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 127
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 127
Use of nifedipine in the treatment of hypertension. 124
Creatinine clearance and early signs of target organ damage in primary hypertension 123
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 122
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 121
Mild renal dysfunction and renal vascular resistance in primary hypertension 120
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 120
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 120
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 119
Highlights from International Congress 119
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 119
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 119
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 119
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 118
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 117
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 117
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 117
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 117
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 117
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 117
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 116
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 116
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 116
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 116
Renal ammoniagenesis in man with chronic potassium depletion. 115
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 115
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 114
Overall health assessment: a renal perspective. 114
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 114
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 114
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 114
Renal and cardiac abnormalities in primary hypertension 113
Hyperuricemia and renal risk 113
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 112
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 112
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 112
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 112
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 112
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 111
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 111
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 111
Blood pressure variability and multiple organ damage in primary hypertension 111
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 111
Microalbuminuria in primary hypertension: a guide to optimal patient management? 110
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 110
Hypernatremia associated with severe rhabdomyolysis. 109
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 108
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 108
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 108
Amino acid imbalance in patients with chronic renal failure. 108
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 108
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 108
Chronic kidney disease and albuminuria in arterial hypertension. 108
Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy 108
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 107
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 107
RAAS Inhibition and Renal Protection 107
Diffusion-weighted MRI sequences (DW-MRI) of the kidney: normal findings, influence of hydration state and repeatibility of results 107
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 106
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 106
microalbuminuria in essential hypetension: its relation to cardiovascular risk factors 105
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 105
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 105
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 105
Vascular permeability, blood pressure, and organ damage in primary hypertension 105
Serum uric acid as a marker of target organ damage in primary hypertension 104
Renal ammoniagenesis in humans with chronic potassium depletion 104
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 104
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 104
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy 102
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 102
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 102
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 102
Sub-clinical organ damage in hypertension and obesity 101
Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative 101
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 101
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk 101
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 100
Totale 11.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.064
article - articoli 67.609
book - libri 0
conference - conferenze 0
curatela - curatele 293
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 162
Totale 136.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.335 0 0 0 0 575 762 1.067 482 646 976 629 198
2020/20212.223 115 219 191 169 109 169 209 226 188 260 157 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.616 263 159 24 273 386 471 47 209 449 62 214 59
2023/20241.401 72 198 36 146 133 266 72 83 82 14 93 206
2024/20251.204 104 344 150 298 308 0 0 0 0 0 0 0
Totale 21.779